Skip to content
Unrated Drug recall · FDA · Published February 22, 2022

Preferred Pharmaceuticals recalls Xanax 1mg tablets due to manufacturing deviations

Preferred Pharmaceuticals recalls Alprazolam 1mg tablets (NDCs 68788-6381-03, 06, 09) for CGMP deviations. Consumers should check lot numbers and expiration dates on packaging.

🇺🇸 FDA recall #D-0642-2022DrugPreferred Pharmaceuticals ›
Take action

Contact the company

Recalling firmPreferred Pharmaceuticals, Inc.1250 N Lakeview Ave Ste O · Anaheim, CA 92807-1801
✎ GovInfoNow plain-language explainer

Preferred Pharmaceuticals is recalling certain Xanax 1mg tablets due to manufacturing deviations. This recall is important because the issue could affect product safety and quality. Read more at govinfonow.com/recall/35208-preferred-pharmaceuticals-recalls-xanax-1mg-tablets-due-to-manufacturing-deviations.

Source Summary by GovInfoNow · govinfonow.com/recall/35208-preferred-pharmaceuticals-recalls-xanax-1mg-tablets-due-to-manufacturing-deviations · Updated August 18, 2026 · FDA enforcement record: FDA #D-0642-2022

Cite this page

“Preferred Pharmaceuticals recalls Xanax 1mg tablets due to manufacturing deviations.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/35208-preferred-pharmaceuticals-recalls-xanax-1mg-tablets-due-to-manufacturing-deviations. Based on FDA recall #D-0642-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0642-2022%22&limit=1).

The FDA announced on Feb. 22, 2022, that Preferred Pharmaceuticals voluntarily recalled Alprazolam Tablets USP 1mg due to CGMP deviations. The recall affects specific lots distributed nationwide.

How to tell if you have it

  • Brand: Preferred Pharmaceuticals
  • Product: Alprazolam Tablets, USP 1mg, Generic for Xanax
  • NDCs: 68788-6381-03 (30 tablets), 68788-6381-06 (60 tablets), 68788-6381-09 (90 tablets)
  • Lot codes: G2919M, I0619O, F1419J, H3019Q, F1219N, F1919D, H0219D, I0519R, J0319G
  • Expiration date: 03/31/2022
  • Units affected: 276 bottles

The hazard

The recall was issued due to CGMP deviations. The FDA classified the recall as Class II.

Context

GovInfoNow's records show Preferred Pharmaceuticals, Inc. has had 32 other recalls on record since Aug. 15, 2018. Other recent recalls of similar products include Preferred Pharma Recalls Lidocaine Ointment Due to Content Issues (Sept. 28, 2026), Geri-Care Eye Drops Recalled for Sterility Risk (March 25, 2026), and Preferred Pharma Recalls Ondansetron ODT Due to Defective Seals (Nov. 17, 2025). Other recent recalls of similar products include Wells Pharma fentanyl injectable solution recall due to manufacturing deviations, Wells Pharma Fentanyl Citrate Recall: Cgmp Deviations Risk, and Wells Pharma Fentanyl Citrate Injectable Solution Recall: Cgmp Deviations (all April 1, 2026).

How to tell if you have this one

Check the product packaging for the NDC codes: 68788-6381-03 (30 tablets), 68788-6381-06 (60 tablets), or 68788-6381-09 (90 tablets). Also look for the lot numbers and expiration date (03/31/2022) on the bottle.

  • Brand
    Preferred Pharmaceuticals
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Look for the NDC codes and lot numbers on the packaging to confirm if the product is recalled.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide in the USA.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 14 months after the firm started it.

1. Firm started the recall: Feb 22, 202212. FDA classified it Class II: Mar 1, 202223. Published in FDA’s Enforcement Report: Mar 9, 202234. FDA terminated the recall: May 5, 2023420222023
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Preferred Pharmaceuticals recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0642-2022 (February 22, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0642-2022 to see it in context.
  • Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA